These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 6072354)
41. Studies of EN-1639A (naltrexone): a new narcotic antagonist. Resnick RB; Volavka J; Freedman AM; Thomas M Am J Psychiatry; 1974 Jun; 131(6):646-50. PubMed ID: 4827793 [No Abstract] [Full Text] [Related]
42. Current trends in narcotic addiction treatment: patient acceptability and clinical applicability of alternative treatment methods. Kissin B; Arnon D; Luckom-Nurnberg F Ann N Y Acad Sci; 1978; 311():282-95. PubMed ID: 283725 [No Abstract] [Full Text] [Related]
43. Pharmacological approaches to the treatment of morphine-type dependence. Halbach H Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):6-12. PubMed ID: 1165143 [TBL] [Abstract][Full Text] [Related]
44. Current approaches to the treatment of narcotic addiction. Maddux JF J Natl Med Assoc; 1969 May; 61(3):248-54 passim. PubMed ID: 4892689 [No Abstract] [Full Text] [Related]
45. Drug scene in Alaska. Hilburn MB Alaska Med; 1972 Jan; 14(1):26-9. PubMed ID: 5063400 [No Abstract] [Full Text] [Related]
46. Toward a rational selection of treatment for addiction. O'Brien CP Curr Psychiatry Rep; 2007 Dec; 9(6):441-2. PubMed ID: 18221622 [No Abstract] [Full Text] [Related]
47. Addiction and the community. (Narcotic substitution therapy). Taylor WJ; Chambers CD; Bowling CE Int J Clin Pharmacol; 1972 Apr; 6(1):28-39. PubMed ID: 4625924 [No Abstract] [Full Text] [Related]
48. Intravenous diacetylmorphine (heroin) in studies of opiate dependence. Zaks AM; Bruner A; Fink M; Freedman AM Dis Nerv Syst; 1969 Feb; 30(2):Suppl:89-92. PubMed ID: 4886996 [No Abstract] [Full Text] [Related]
49. Newer treatment approaches for drug addiction. Conrad HT Med Arts Sci; 1971; 25(1):15-32. PubMed ID: 5155704 [No Abstract] [Full Text] [Related]
50. Insufficient information in drug-related hospital morbidity study. Newman RG Arch Gen Psychiatry; 2009 Mar; 66(3):331; author reply 331-2. PubMed ID: 19255384 [No Abstract] [Full Text] [Related]
51. Cyclazocine in the treatment of narcotic addiction. Jaffe JH Curr Psychiatr Ther; 1967; 7():147-56. PubMed ID: 4860298 [No Abstract] [Full Text] [Related]
53. [Withdrawal programmes for narcotics addicts in the USA]. Neudek K Munch Med Wochenschr; 1970 May; 112(22):1054-6. PubMed ID: 4987316 [No Abstract] [Full Text] [Related]
55. Use of street methadone in italian heroin addicts presenting for opioid agonist treatment. Maremmani I; Pacini M; Pani PP; Popovic D; Romano A; Maremmani AG; Deltito J; Perugi G J Addict Dis; 2009 Oct; 28(4):382-8. PubMed ID: 20155607 [TBL] [Abstract][Full Text] [Related]
56. Recent developments in chemotherapy of narcotic addiction, 3-4 November 1977, Washington, D.C.: proceedings. Ann N Y Acad Sci; 1978; 311():1-315. PubMed ID: 33587 [No Abstract] [Full Text] [Related]
57. The role of the federal government in the development of narcotic antagonists. Green AI Adv Biochem Psychopharmacol; 1973; 8(0):576-7. PubMed ID: 4795123 [No Abstract] [Full Text] [Related]
58. On understanding and treating narcotic dependence: a neuropsychopharmacological perspective. Ng LK; Szara S; Bunney WE Br J Addict Alcohol Other Drugs; 1975 Sep; 70(3):311-24. PubMed ID: 1059467 [No Abstract] [Full Text] [Related]
59. Recovery from drug dependence. JAMA; 1970 Oct; 214(3):579. PubMed ID: 5469030 [No Abstract] [Full Text] [Related]
60. The case for success in narcotic drug addiction. Davis EP; Parnes JN Md State Med J; 1971 May; 20(5):63-5. PubMed ID: 5563031 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]